![William Avery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Avery
Directeur Financier/CFO chez
PHARMALA BIOTECH HOLDINGS INC.
Fortune : 194 250 $ au 31/08/2026
Profil
William Avery currently works at ICG Silver & Gold Ltd., as Chief Financial Officer, Pharmala Biotech Holdings, Inc., as Chief Financial Officer from 2024, and Jaguar Uranium Corp., as Chief Financial Officer from 2024.
Mr. Avery also formerly worked at MNP LLP, as Partner.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/04/2026 | 1 000 000 ( 0,92% ) | 162 000 $ | 31/08/2026 | |
0,35% | 31/03/2026 | 150 000 ( 0,35% ) | 32 250 $ | 31/08/2026 |
-.--% | 10/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de William Avery
| Sociétés | Poste | Début |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur Financier/CFO | 30/09/2024 |
Anciens postes connus de William Avery
| Sociétés | Poste | Fin |
|---|---|---|
MNP LLP
 MNP LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, consulting, tax and digital services | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MNP LLP
MNP LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, consulting, tax and digital services | Commercial Services |
PharmAla Biotech Holdings, Inc.
 PharmAla Biotech Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and sells pharmaceutical ingredients | Health Technology |
